Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy

Fig. 4

In vivo tumor accumulation and anticancer effect of NP@Pt-1 on a CT26 murine colon cancer model. A In vivo biodistribution of Cy7.5 labeled NP@Pt-1 via fluorescence imaging. B Quantitative measurement of Cy7.5 labeled NP@Pt-1. C Ex-vivo fluorescence imaging of various organs and tumors at 36 h after intravenous administration. D Quantitative study of ex-vivo fluorescence distribution of various organs and tumors at 36 h after intravenous administration. E Schematic illustration of the timeline of in vivo treatment on a CT26 murine colon cancer model. F Tumor growth inhibition curves after various treatment. G Ex-vivo tumor weight measurement after various treatment. H Ex-vivo tumor imaging after various treatment (n = 5, ***p < 0.001).

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us